Neoplasm Metastasis Clinical Trial
Official title:
Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases: First-in-Man Study According to the IDEAL Recommendations
The aim of this study is to assess the feasibility and safety of combining stereotactic body radiotherapy (SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable metastases of the thoracic and/or lumbar spine.
Rationale: Sixty-five percent of cancer patients with terminal illness have bone metastases,
with debilitating pain as devastating consequence. The spine is the most common location for
bone metastases. Spinal cord compression is present in 10% of patients with vertebral
metastases and aggravates pain and performance status even further. Standard treatment of
unstable vertebral metastases consists of stabilizing surgery, followed by external beam
radiotherapy (8 Gy) after two weeks. Although this approach is effective in 60-70% of
patients, it is has several downsides. Firstly, because of the two weeks interval between
surgery and external beam radiotherapy, necessary for sufficient wound healing, it takes a
long time before radiotherapy induced pain relief is achieved. Scatter artifacts on planning
computed tomography images caused by surgical implants prohibit high-resolution imaging and
accurate targeting of the lesion. Multiple hospital visits (+/- 10) are needed for
administration of external beam irradiation, and in about 30-40% of patients no adequate
pain response is achieved. An alternative treatment strategy, which would lead to faster
pain relief in a higher proportion of patients with less hospital visits, would be highly
desirable from the patient's perspective.
Objective: To assess the feasibility and safety of combining stereotactic body radiotherapy
(SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable
metastases of the thoracic and/or lumbar spine.
Study design: Prospective case series (13), first in man study, Phase I and II a study
according to the IDEAL recommendations
Study population: All patients, male and female, with impending spinal stability requiring
radiation therapy and surgical intervention at the University Medical Center Utrecht
Main study parameters/endpoints: The main outcome of this study is safety of the combined
procedure, defined as grade 3 or higher treatment-induced toxicity according to common
terminology criteria for adverse events (CTC-AE) 4.0 as a result of the procedure within 60
days after the surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Terminated |
NCT03166631 -
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Active, not recruiting |
NCT03775980 -
CIRSE Emprint Microwave Ablation Registry
|
||
Completed |
NCT01114958 -
Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
|
Phase 1 | |
Terminated |
NCT03986593 -
Cryoablation of Bone Metastases From Endocrine Tumors
|
N/A | |
Active, not recruiting |
NCT04458259 -
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
|
Phase 1 | |
Completed |
NCT01218542 -
Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc
|
N/A | |
Not yet recruiting |
NCT03175146 -
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
|
N/A | |
Active, not recruiting |
NCT02395224 -
A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway
|
||
Completed |
NCT02374411 -
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
|
N/A | |
Recruiting |
NCT01960829 -
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
|
Phase 2 | |
Terminated |
NCT01846429 -
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
|
Phase 1 | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Recruiting |
NCT01564810 -
Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
|
Phase 4 | |
Completed |
NCT00375245 -
Rapamycin With Grapefruit Juice for Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00232726 -
Clinical Study of Previously Untreated Patients With Malignant Melanoma
|
Phase 2 | |
Completed |
NCT00207116 -
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma
|
Phase 1 | |
Completed |
NCT00207103 -
MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Completed |
NCT00172003 -
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
|
Phase 4 |